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Myocilin is expressed in the glomerulus of the kidney and in-
duced in mesangioproliferative glomerulonephritis.
Background. Myocilin is a 55 to 57 kD secreted glycoprotein
and member of the olfactomedin protein family. It is expressed
in high amounts in the outflow tissues of the aqueous humor in
the eye where it is supposed to contribute to outflow resistance.
Myocilin is mutated in some forms of primary open angle glau-
coma and affected patients show very high intraocular pressures
because of an increase in resistance to aqueous humor outflow.
To obtain information, if myocilin may play a comparable role
in other tissues with transendothelial fluid flow, we investigated
its expression in the rat kidney.
Methods. The expression of myocilin in the normal rat kidney
and its changes during mesangioproliferative glomerulonephri-
tis were investigated by immunohistochemistry, one- and
two-dimensional gel electrophoresis with Western blotting, and
reverse transcription-polymerase chain reaction (RT-PCR).
Results. Myocilin and its mRNA were detected in isolated
glomeruli. Immunohistochemistry showed specific labeling of
glomerular cells, while tubular and interstitial regions were es-
sentially negative. Double staining with the podocyte-specific
markers synaptopodin and ezrin indicated that myocilin-
positive cells were predominately podocytes. During mesan-
gioproliferative glomerulonephritis, an induction of myocilin
immunoreactivity was observed. Labeling for myocilin was now
observed in activated mesangial cells and areas of glomerular
sclerosis. In parallel cell culture experiments, mRNA for my-
ocilin was detected in cultured murine podocytes and rat mesan-
gial cells.
Conclusion. Myocilin is expressed in podocytes of the kidney
and induced in mesangial cells during experimental mesangio-
proliferative glomerulonephritis. The specific function of my-
ocilin in the kidney is not clear, but in a parallel to functions
of other olfactomedin proteins, it might have a role in cell-cell
adhesion and/or signaling processes.
Key words: podocyte, mesangium, anti-Thy 1 disease, olfactomedin
proteins.
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Podocytes are highly differentiated cells that are es-
sential for glomerular function [1]. They cover the exte-
rior surface of the glomerular basement membrane and
form multiple interdigitating foot processes, which are
connected by slit diaphragms. The structural integrity of
the slit diaphragm is critically required for maintenance
of the selective permeability of the glomerular filtration
barrier. In addition, podocytes are thought to stabilize
glomerular architecture and to counteract the distensions
of the glomerular basement membrane, which are caused
by the high pressure perfusion of glomerular capillar-
ies. In order to serve these functions, podocytes need to
synthesize a specific set of proteins, some of which are
podocyte-preferred or specific. A considerable number
of these proteins have been identified in recent years,
which has greatly added to our understanding of podocyte
function. Prominent examples are nephrin, neph1, and
podocin, which have been shown to be essential for the
integrity of the slit diaphragm. Nevertheless, our knowl-
edge about number and nature of podocyte proteins is
still incomplete.
In a recent study it was shown that the glycoprotein
noelin (also known as olfactomedin-related glycopro-
tein or pancortin [2, 3]) is expressed in podocytes of
the rat kidney [4]. Noelin belongs to the family of ol-
factomedin proteins [5], which are characterized by their
olfactomedin domain [6, 7]. In general, noelin is found in
four splice variants (noelin-1 through -4, or BMZ, AMZ,
BMY, and AMY), of which the two longer ones (noelin-1
and -2, or BMZ and AMZ) contain the olfactomedin do-
main [2, 8]. Podocytes of the rat kidney express noelin-2
or BMZ, and smaller amounts of noelin-3 or BMY [4].
In addition to the kidney, noelin is highly expressed in
the rat and mouse brain [2, 3]. In chicken [8] and mouse
[9] embryos, noelin is expressed in the developing neural
tube and neural crest, where it appears to be an important
signaling molecule as overexpression prolongs the “com-
petent period” of the neural tube to generate neural crest
cells [8].
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The prototype of the olfactomedin family, olfac-
tomedin, was originally discovered in the bullfrog and
identified as the major glycoprotein of the extracellular
mucous layer surrounding the chemosensory dendrites of
the olfactory neuroepithelium [10, 11]. Another promi-
nent member of the olfactomedin family is myocilin, a 55
to 57 kD secreted glycoprotein, which forms larger dimers
and multimers [5]. Myocilin is highly expressed in the tis-
sues of the mammalian anterior eye such as cornea, sclera,
and trabecular meshwork [12–15], the main outflow site
of aqueous humor. In addition, a considerable expres-
sion has been observed in myelinated peripheral nerves,
where myocilin is mainly localized at the abaxonal mem-
brane of Schwann cells [16]. Mutations in myocilin are
responsible for some forms of primary open-angle glau-
coma [17], a neurodegenerative disease that may lead to
permanent optic nerve damage and blindness [18]. De-
pending on the respective site of the mutation, affected
patients may suffer from a massive increase in intraocular
pressure [19], which is caused by an increase in outflow
resistance in the trabecular meshwork. Aqueous humor
percolates through the trabecular meshwork before it
passes Schlemm’s canal endothelium to reach the venous
system [20]. Up until now, a specific function of myocilin
for aqueous humor outflow has not been identified, but
experimental in vitro perfusion of the trabecular mesh-
work with high amounts of recombinant myocilin causes
a marked increase in resistance to flow [21]. In the present
study, we were interested, if myocilin plays a parallel role
in other tissues with larger amounts of transendothelial
fluid flow and investigated its expression in the glomeru-
lus of the rat kidney.
Our results show that in vitro myocilin is expressed
in both podocytes and mesangial cells. In situ, myocilin
is mainly localized in glomerular podocytes. During ex-
perimental mesangial proliferative glomerulonephritis,




Male Sprague Dawley rats (150 to 200 g) were ob-
tained from Charles River, Sulzfeld, Germany. Ex-
perimental mesangial proliferative glomerulonephritis
(anti-Thy 1 model) was induced by a single intravenous
injection of anti-Thy 1 antibodies into the tail vein (1
mg/kg body weight). Two monoclonal antibodies were
used; ER4 (described by Bagchus, Jeunink, and Elema
[22]) was a kind gift from Emile de Heer (University of
Leiden, The Netherlands) and OX-7 (European Collec-
tion of Animal Cell Culture, Salisbury, UK) was kindly
provided by Christian Hugo (University of Erlangen-
Nu¨rnberg, Germany). A 24-hour urine collection was
done from days 2 and 3, 4 and 5, 7 and 8, and 11 and 12.
For ER4 experiments, groups of four animals were killed
on days 2, 6, and 12 after induction of nephritis; for OX-7
experiments, groups of four animals were killed on days
3, 5, 8, and 12, respectively. Renal tissue was obtained for
further preparation. Control animals were injected iso-
tonic saline into the tail vein and killed on days 2, 6, or 12
(ER4), or days 3, 5, 8, or 12 days (OX-7) after injection.
Cell culture
A clonal murine podocyte cell line carrying a
temperature-sensitive mutant of the SV40 large T-antigen
under control of the c-interferon (INF-c)-inducible H-
2Kb promoter was kindly provided by Karlhans Endlich
(University of Heidelberg, Germany), and cultured as
described previously [23]. mRNA was isolated from
differentiated cells, and differentiation was induced by
maintaining the cells at 38◦C without INF-c for at least
1 week. Rat mesangial cell cultures were initiated, char-
acterized, and cultured according to protocols published
elsewhere [24, 25]. Before mRNA extraction, mesangial
cells were serum-deprived for 4 days in medium contain-
ing 0.4% fetal bovine serum (FBS), which served to syn-
chronize the majority of mesangial cells to a quiescent
state.
Immunohistochemistry
After sacrifice of the animals, dissected kidney samples
were fixed in 4% paraformaldehyde or methyl-Carnoy
solution overnight, embedded in paraffin according to
standard protocols and processed for immunohistochem-
istry. Five micrometer sections were cut on a micro-
tome, placed on microscopic slides (SuperFrost/Plus)
(Menzel, Braunschweig, Germany) and preincubated for
30 minutes in dry milk solution. After preincubation, the
sections were incubated overnight at 4◦C with rabbit or
chicken antimyocilin antibodies diluted 1:100 to 1:300 in
phosphate-buffered saline (PBS) containing 2% bovine
serum albumin (BSA). The rabbit antibodies had been
developed by immunizing against the peptide sequence
TRDTARAVPPGSREVST, corresponding to position
188 to 204 of human myocilin. The peptide sequence for
the chicken antibodies was KSELTEVPASRILKES cor-
responding to position 215 to 231 of human myocilin.
The rabbit antibodies had been characterized in previ-
ous studies on human [26, 27], mouse, and rat [16] ocular
tissues, and rat sciatic nerve [16]. Chicken antimyocilin
antibodies were a kind gift of Paul Russell (National
Eye Institute, Bethesda, MD, USA) and were affinity
purified. After overnight incubation, the sections were
washed in PBS, reacted for 1 hour with a biotinylated
secondary antibody against rabbit immunoglobulin (Vec-
tor Laboratories, Burlingame, CA, USA), washed again
and covered with streptavidin-fluorescein isothiocyanate
(FITC) (Vector Laboratories). Control experiments were
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performed by using preimmune serum substituted
for the primary antibody. For double-labeling experi-
ments, sections were incubated with chicken or rab-
bit antimyocilin antibodies in combination with mouse
anti-a-smooth muscle actin (a-SMA) monoclonal anti-
bodies (1:200) (clone A2547) (Sigma Chemical Co., St.
Louis, MO, USA), rabbit antifibronectin (1:200) (Dako,
Glostrup, Denmark), mouse antisynaptopodin (clone
G1D4) (Progen, Heidelberg, Germany), mouse antiezrin
(1:50) (clone 3C12) (Neomarkers, Fremont, CA, USA) or
the anti-Thy 1 epitope (OX-7). Binding of antimyocilin
antibodies was visualized using biotinylated secondary
antibodies and streptavidin-FITC. Other antibodies were
stained with Cy 3-conjugated antimouse or antirabbit IgG
(Dianova, Hamburg, Germany). Control experiments
were performed by using PBS or preimmune serum from
the same host species substituted for the primary anti-
body. After washing in PBS, the sections were mounted
with fluorescent mounting medium (Dako). Slides were
viewed on a fluorescent microscope (Aristoplan) (Ernst
Leitz GmbH, Wetzlar, Germany), or a confocal micro-
scope (MRC 1000) (Bio-Rad, Cambridge, UK) with the
appropriate filter settings for FITC (channel 2), and Cy 3
or background fluorescence (channel 1). Channel 1 and
channel 2 were coded red and green, respectively. Single
optical sections of 1 lm were created and electronically
superimposed.
Protein analysis
For protein analysis, glomeruli were isolated by differ-
ential sieving, lysed in NP40 sample buffer [0.5% NP40,
50 mmol/L Tris, 2 mmol/L ethylenediaminetetraacetic
acid (EDTA), 137 mmol/L NaCl, 10% (vol/vol) glycerol,
and 1 mmol/L phenylmethylsulfonyl fluoride (PMSF)]
and centrifuged at 14,000g for 10 minutes. The super-
natant was taken for gel analysis. Protein content was
measured using Bradford protein assay reagent (Bio-Rad
Laboratories, Mu¨nchen, Germany). Prior to gel anal-
ysis, the protein samples were boiled for 10 minutes.
For one-dimensional Western blot analysis, the proteins
(10 lg) were separated by electrophoresis using a 5%
sodium dodecyl sulfate (SDS) polyacrylamide stacking
gel and a 12% SDS polyacrylamide separating gel, or
a 6% to 15% (wt/vol) gradient gel. After electrophore-
sis, the proteins were transferred with semidry blotting
(Bio-Rad) on a polyvinyl difluoride (PVDF) membrane
(Roche, Mannheim, Germany). The membrane was in-
cubated with PBS containing 5% BSA for 10 minutes.
Polyclonal rabbit or chicken antibodies against myocilin
(diluted 1:500) were added and allowed to react overnight
at 4◦C; for negative controls, antibodies were incubated
with equal amounts of immunizing peptide or preim-
mune serum was used at the same concentration. After
washing with PBS containing 0.1% Tween-20 (PBST), pH
7.2, an alkaline phosphatase-conjugated goat antirabbit
IgG (diluted 1:10,000) (Promega, Mannheim, Germany)
was added for 30 minutes. Visualization of the alkaline-
phosphatase was achieved by chemiluminescence.
Disodium 4-chloro-3-(mothoxyspiro {1,2-dioxetane-3,2-
(5-chloro)tricyclo[3.3.1.13.7]decan}-4-yl) phenyl phos-
phate (CDD-Star) was diluted 1:100 in detection buffer
(100 mmol/L Tris/HCl, pH 9.5, 100 mmol/L NaCl) and the
filters were incubated for 5 minutes at room temperature.
Chemiluminescence was detected on a Lumi-Imager
workstation (Roche). Exposure time ranged between 1
and 15 minutes. The intensity of the hybridization signal
was determined by the Lumi-Analyst software (Roche).
For two-dimensional gel electrophoresis, 2 lg proteins
were subjected to isoelectric focusing on immobilized pH
gradient strips (IPG ReadyStripTM) (Bio-Rad) with pH
ranging from 3 to 10 in 8 mol/L urea, 10 mmol/L dithio-
threitol (DTT), 0.2% Bio-Lytes in 4% (vol/vol) CHAPS
buffer. Molecular weight separation was done on a 6 to
15% (wt/vol) SDS-polyacrylamide gel, followed by silver
staining of the gel using standard techniques or blotting
to a PVDF membrane as described above. Positive con-
trols were performed with recombinant myocilin that was
isolated from a eucaryotic expression system as described
previously [26].
RNA analysis
Total RNA was isolated from isolated rat glomeruli
or from cultured cells by using TRIzol (Invitrogen,
Karlsruhe, Germany) according to the manufacturer’s
instructions. For reverse transcription-polymerase chain
reaction (RT-PCR) detection of myocilin mRNA in
glomerular RNA and cultured mesangial cells, se-
quences of primer pairs for rat myocilin were 5′-GGGT
CAGATCCCTGGAGAGT–3′ and 5′-ACCGTGTCAA
TCCTCCAAGT-3′. For detection of myocilin mRNA
in mouse podocytes, sequences of primer pairs
were 5′-TTCCAGAAGAAACCTCACCCA-3′ and 5′-
GGCCAACGTGTCCAAATTC. Sizes of the expected
PCR-products were 598 bp and 662 bp, respectively.
Sequences of primer pairs crossed exon-intron bound-
aries. For controls, the RT step was omitted (minus
RT control) or RT-PCR was performed without adding
cDNA (negative control). The RT was performed by
using Superscript II RT (Invitrogen) according to the
manufacturer’s protocol. The PCR was performed in
a final volume of 50 lL by denaturation at 94◦C for
2 minutes, followed by 35 cycles of 30 seconds at 94◦C,
30 seconds annealing at 55◦C, and 90 seconds exten-
sion at 72◦C. After the last cycle, the extension time
was 10 minutes. PCR products were gel-purified by using
the GFX PCR-Kit (Amersham Pharmacia Biotech Inc.,
Piscataway, NJ, USA), cloned into pCR II-Topo (Invit-
rogen) and analyzed by automated sequencing with fluo-
rescent dideoxynucleotides (Applied Biosystems Model
310) (Perkin Elmer, Hayward, CA, USA). As positive
control, RNA isolated from rat eyes was used.
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Fig. 1. Immunoreactivity for myocilin (Myoc) in the normal rat kidney. Paraffin sections were incubated with rabbit (A, C, and D) or chicken
antibodies against myocilin (E), preimmune serum (B), or chicken antibodies preabsorbed with the immunizing peptide at equimolar concentration
(F). Both antisera were generated against different regions of myocilin. Positive immunoreactivity is seen in cells of the glomeruli, while tubular
and interstitial areas do not show specific immunoreactivity. Upon higher magnification, the location of immunoreactive cells is consistent with the
synthesis of myocilin in podocytes (D, arrows) [magnification bars (A and B) 100 lm, (C) 33 lm, (D) 4 lm].
RESULTS
Myocilin and its mRNA are expressed in the glomerulus
In the normal rat kidney, cells of the glomeruli showed
positive immunoreactivity for myocilin, while no intersti-
tial or tubular staining was observed (Fig. 1A). Glomeru-
lar staining was confined to the cytoplasm of cells, and no
extracellular labeling in the mesangium or the glomeru-
lar basement membrane was observed. The location of
immunoreactive cells was consistent with the synthesis
of myocilin in podocytes (Fig. 1C to E). The glomeru-
lar staining pattern obtained with two different poly-
clonal antisera against different regions of myocilin was
essentially similar. Control sections in which antibod-
ies had been preabsorbed with the immunizing pep-
tide at equimolar concentration (Fig. 1F), or which were
incubated with preimmune serum showed no staining
(Fig. 1B).
















Fig. 2. Two-dimensional Western blot analysis of proteins from iso-
lated glomeruli (Glom) (A), rat eye without the lens (Eye) (B) and
human recombinant myocilin (rMyoc) (C). After blotting, the mem-
branes were incubated with a peptide antibody specific against human
myocilin. Distinct spots with similar isoelectric point (pI) and molecular
weight as human recombinant myocilin were detected in proteins from
both rat glomeruli and rat eye, which was used as additional positive
control (arrows).
By two-dimensional SDS-polyacrylamide gel elec-
trophoresis (PAGE) and Western blot analyses of iso-
lated rat glomerular proteins, a distinct dot was labeled,
which was immunoreactive for myocilin (Fig. 2A). A dot



















Fig. 3. Detection of myocilin mRNA in RNA from isolated rat
glomeruli (Glom). By reverse transcription-polymerase chain reaction
(RT-PCR) analysis, distinct bands with expected molecular weight (ar-
row) were amplified from glomerular RNA and eye RNA, which was
used as positive control. The RT step was omitted in –RT controls. The
identity of the PCR products was confirmed by automatic sequencing,
the primer pairs crossed exon-intron boundaries.
lar weight was identified in parallel experiments on pro-
teins from the rat eye (Fig. 2B), which were used as pos-
itive control. A comparable two-dimensional migration
pattern of myocilin was observed for human recombinant
myocilin (Fig. 2C), and had been reported in other studies
using proteins from the rat sciatic nerve [16] and human
ocular tissues [27–29] and cells [30]. The two spots that
were seen in recombinant myocilin are consistent with the
known translational and posttranslational processing of
human myocilin [30]. Control blots, in which preimmune
serum was used, or the antibodies had been preabsorbed
with immunizing peptide were consistently negative (not
shown).
To analyze mRNA expression of myocilin in the rat
glomerulus, RT-PCR was performed with RNA isolated
from fresh rat glomeruli. RNA isolated from the rat eye
served as positive control. Distinct positive products were
amplified from both RNA samples, which each migrated
at the expected molecular weight (Fig. 3). The identity of
each product was confirmed by sequencing. No product
was amplified in parallel control experiments, in which
the RT step had been omitted (Fig. 3).
Glomerular myocilin is predominately localized to
podocytes
To characterize the glomerular cell types that express
myocilin, double-labeling experiments were performed.
Double immunohistochemistry with antibodies against
both myocilin and the podocyte-specific markers ezrin
(Fig. 4A to C), or synaptopodin (Fig. 4D to F) clearly
showed that cells with intense immunoreactivity for my-
ocilin were podocytes that were also labeled for ezrin or
synaptopodin. Ezrin and synaptopodin immunoreactivity
was confined to areas close to podocyte cell membrane
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Fig. 4. Double immunohistochemistry of rat glomeruli with antibodies against myocilin (Myoc) (A, D, G, and J), the podocyte markers ezrin (B)
and synaptopodin (Syn) (E), and the mesangial epitope Thy 1 (H and K). Double immunohistochemistry with antibodies against both myocilin and
ezrin (C), or myocilin and synaptopodin (F) clearly show that the cells with intense immunoreactivity for myocilin are podocytes, which are also
labeled for ezrin or synaptopodin (solid arrows). In double-labeling experiments with antibodies against both myocilin and the mesangial marker
Thy 1 (I and L), the cells with intense immunoreactivity for myocilin are Thy 1–negative (open arrows) while Thy 1–positive cells express no or
only minimal immunoreactivity for myocilin (solid arrows) (magnification bars (A to C) 30 lm, (D to F) 10 lm, (G to I) 35 lm, and (J to L) 15 lm].
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Fig. 5. Immunoreactivity for myocilin in rat glomeruli at day 6 of anti-Thy 1 nephritis. (A) Intense myocilin staining is seen in affected glomeruli
(arrows), while sections treated with preimmune serum are unstained (B) (magnification bars 35 lm). (C and D) Western blotting for myocilin
(Myoc) and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (Coomassie-blue stained) of glomerular proteins in two
independent experiments. For separation, a 6% to 15% (wt/vol) gradient gel (C) or 12% SDS separating gel (D) was used. Proteins were isolated at
either days (d) 2, 6, and 12 of anti-Thy 1 nephritis (C), or at days 3, 5, 8, and 12 (D). Control proteins were isolated from day 6 (C) or day 8 control
(Co) animals (D). As compared to controls, a stronger intensity of the band that is immunoreactive for myocilin is seen at day 6 in (C) and days 5
and 8 in (D) (arrows). Coomassie-blue stained membranes confirm equal loading of proteins.
and foot processes. A similar immunostaining has been
described by others and is consistent with the role of ezrin
and synaptopodin as actin-associated proteins [31, 32]. In
contrast, staining for myocilin appeared to be homoge-
nously distributed throughout the podocyte cytoplasm. In
double-labeling experiments with antibodies against both
myocilin and the mesangial marker Thy 1, cells with in-
tense immunoreactivity for myocilin were Thy 1–negative
(Fig. 4G to L) and Thy 1–positive cells expressed no or
only minimal immunoreactivity for myocilin.
Myocilin is induced in mesangioproliferative
glomerulonephritis
In cells of the trabecular meshwork in the eye, in which
myocilin was identified first, the expression of myocilin is
under the influence of fibroblast growth factor-2 (FGF-
2) and transforming growth factor-b1 (TGF-b1) [13, 30].
As both growth factors are thought to be causatively
involved in the pathogenesis of mesangioproliferative
glomerulonephritis [33–35], we studied the expression of
myocilin in the anti-Thy 1 rat model of mesangioprolifer-
ative glomerulonephritis. Intense glomerular immunore-
activity for myocilin was observed at day 6 of animals in
which anti-Thy 1 nephritis was induced by treatment with
antibodies of clone ER4 (Fig. 5A and B), and at days 5
and 8 of animals treated with antibodies of clone OX-7
(Fig. 6). Western blotting of glomerular proteins showed
that the intense immunoreactivity correlated with an in-
crease in glomerular myocilin (Fig. 5C and D). In both
experimental and control animals, no myocilin could be
detected in Western blots from urine.
In mesangioproliferative nephritis, myocilin is localized
in cells of the mesangium
To identify the cells that were immunoreactive for
myocilin during anti-Thy 1 nephritis, double-labeling
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Fig. 6. Double immunohistochemistry of rat glomeruli at days 6 (day 6) (D to F) and 8 (day8) (A to C and J to O) of anti-Thy 1 nephritis, and in
control (Co) animals (G to I and P to R). Sections were stained with antibodies against myocilin (Myoc) (A,D, G, J, M, and P), synaptopodin (Syn)
(B, E, and H), a-smooth muscle actin (Ac) (K), or fibronectin (Fn) (N and Q). (C, F, and I) Myocilin staining combined with staining for the podocyte
marker synaptopodin (M/S). During anti-Thy 1 nephritis not only synaptopodin-positive podocytes are labeled for myocilin, but also cells of the













Fig. 7. Detection of myocilin mRNA in RNA from a murine podocyte
cell line and cultured rat mesangial cells. By reverse transcription-
polymerase chain reaction (RT-PCR) analysis, distinct bands with ex-
pected molecular weight were amplified from RNA of both cell types.
No cDNA was added to controls (Co). The identity of the PCR-products
was confirmed by automatic sequencing, the primer pairs crossed exon-
intron boundaries.
immunohistochemistry was again performed. When
myocilin staining was combined with staining for
the podocyte marker synaptopodin, not only the
synaptopodin-positive podocytes were labeled for my-
ocilin at days 5 to 8 of anti-Thy 1 nephritis, but also the ac-
tivated cells of the mesangium (Fig. 6A to C), which were
negative for synaptopodin. In animals where anti-Thy 1
nephritis had been induced by antibodies of the clone
ER4, sclerosis caused by a marked accumulation of ex-
tracellular matrix was observed in some of the glomeruli.
Such areas of sclerosis were intensely labeled for myocilin
(Fig. 6D to F). In control animals, myocilin staining was
essentially confined to synaptopodin-positive podocytes
(Fig. 6G to I).
Double immunohistochemistry with antibodies against
both myocilin and a-SMA, a marker for activated mesan-
gial cells [36], confirmed that the cells of the mesangium
were immunoreactive for myocilin (Fig. 6J to L). During
anti-Thy 1 nephritis, cells of the mesangium synthesize
increasing amounts of extracellular matrix components
such as fibronectin [33]. Double-labeling with antibodies
against both fibronectin and myocilin showed overlap-
ping immunoreactivity in large (but not all) areas of the
mesangium (Fig. 6M to O). In contrast, in control animals
myocilin staining remained confined to podocytes, while
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
mesangium (C). Glomerular areas of sclerosis are intensely labeled for myocilin (F). In control animals, myocilin staining is confined to synaptopodin-
positive podocytes (I). (L) Combined a-smooth muscle actin and myocilin (M/A) immunostaining shows that activated cells of the mesangium are
immunoreactive for both myocilin and a-smooth muscle actin. (O and R) Combined fibronectin and myocilin (M/F) immunostaining. The increase
of myocilin immunoreactivity in the mesangium shows partially overlap with that of fibronectin (O). In control animals, myocilin labeling is confined
to podocytes while fibronectin staining is seen in some small patchy areas of the mesangium (R) [magnification bars (A to I) 30 lm, (J to R) 35 lm].
some small patchy areas of fibronectin staining were seen
in the mesangium (Fig. 6P to R).
Myocilin is expressed in cultured podocytes
and mesangial cells
As the immunohistochemical localization of a secreted
protein does not strongly indicate its cellular origin, we
investigated the expression of myocilin in a well differ-
entiated murine podocyte cell line and in cultured rat
mesangial cells. By RT-PCR, distinct positive products
were amplified from RNA of both cell lines, which
each migrated at the expected molecular weight (Fig. 7).
Primers crossed exon-intron boundaries and the identity
of each product was confirmed by sequencing. No prod-
ucts were amplified in parallel control experiments, in
which no cDNA was added.
DISCUSSSION
Our data show that myocilin, a 55 to 57 kD glycoprotein
of the olfactomedin family, is constitutively expressed in
podocytes of the rat kidney. There is substantial evidence
that myocilin is secreted, as it contains a signal sequence
[37], and is found in the aqueous humor of the eye in
vivo [38–41] and in cell culture supernatant in vitro [26,
41, 42]. Still, in the present study, podocyte immunore-
activity for myocilin was predominantly observed in the
cytoplasm. In addition, no myocilin could be detected
in urine from control and experimental animals, indicat-
ing that glomerular cells do not secrete larger amounts
of myocilin, or that myocilin once secreted is degraded
rapidly. In other cell types, some authors have provided
evidence for a cytoplasmic role of myocilin, and have sug-
gested an involvement in Golgi function [43], an associ-
ation with elements of the cytoskeleton [44–46], or an
interaction with mitochondria [44, 47]. Comparable cy-
toplasmic roles of myocilin might also be relevant for
podocytes in the kidney. Another, more likely, possibil-
ity is that our antibodies pick up myocilin while it is
processed for secretion in the rough endoplasmic reticu-
lum and the Golgi apparatus, and that any extracellular
localization of myocilin in the glomerulus (e.g., on the cell
surface of podocytes) is more difficult to distinguish by
light microscopy. Clearly, immune electron microscopy
will be required to clarify this issue. It is interesting to
note that noelin, another prominent member of the olfac-
tomedin family, has been found to be associated with the
Golgi apparatus of podocytes [4]. Based on this finding,
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a contribution of noelin to the function or the struc-
tural maintenance of the Golgi complex has been sug-
gested [4]. Still, similar to myocilin, a Golgi association
of noelin might simply reflect processing of the protein
during secretion as noelin also contains a signal sequence
[2] and experimental in vivo studies indicate secretion of
noelin during neural tube and neural crest development
[8, 48].
As a specific function of myocilin has not been iden-
tified so far [5], the role of myocilin for the biology of
podocytes remains unclear in the moment. Since my-
ocilin is expressed in very high amounts in the trabecular
meshwork of the eye [12, 13, 15], the main outflow path-
way for aqueous humor [20], a role for the modulation
of aqueous humor outflow resistance has been consid-
ered for myocilin [5]. Such a role is supported by some
experimental data. Myocilin in the aqueous humor forms
high-molecular-weight dimers and multimers [39, 40], and
binds tightly to 0.2 lm polycarbonate microporous fil-
ters [39], which have a similar pore size as found in the
trabecular meshwork and which become obstructed, if
aqueous humor is perfused through them [49]. In addi-
tion, experimental perfusion of organ-cultured trabecu-
lar meshwork with recombinant myocilin isolated from
bacteria increases outflow resistance [21], although more
recent studies employing a large C-terminal fragment of
recombinant myocilin isolated from a eukaryotic expres-
sion system are less conclusive [26]. In parallel to the
aqueous humor outflow tissues in the eye, myocilin se-
creted from podocytes may interact with those molecules
that contribute to the glomerular filtration barrier in re-
gion of the podocyte foot process intercellular junction.
This junction appears to require homophilic interactions
of the extracellular parts of nephrin, and the formation
of hetero-oligomers between nephrin and neph1 [50–53],
but at present is unclear how myocilin might contribute
to these interactions. Evidence for a role in cell-cell ad-
hesion has been recently reported for amassin, another
member of the olfactomedin family, which is found in
the sea urchin. Amassin has been shown to mediate the
massive intercellular adhesion that results in clotting of
coelomocytes [54].
The comparison of myocilin with other members of the
olfactomedin family indicates other possible functions.
Noelin is expressed in the developing neural tube and
crest of chicken [8] and mouse [9] embryos, where it ap-
pears to be an important signaling molecule as overex-
pression prolongs the “competent period” of the neural
tube to generate neural crest cells [8]. Signaling functions
have also been attributed to tiarin, an olfactomedin fam-
ily member in Xenopus, which is involved in the signals
that are required for dorsal neural differentiation of the
developing neural tube [55]. A comparable function of
myocilin in podocytes would imply a direct or indirect
contribution to autocrine or paracrine signaling processes
in the adult kidney.
The possible functions of podocyte myocilin are not
mutually exclusive, and to analyze these functions, in
vitro studies employing recombinant myocilin and cul-
tured podocytes are currently underway in our labora-
tory. Additional insight might also come from the analysis
of Myoc−/− knockout mice, which have been generated,
but have not been investigated closer with respect to their
specific kidney function and phenotype [56]. The avail-
able data indicate that myocilin is not critically required
for the structure of the glomerulus as Myoc−/− mice are
viable [56].
In ocular cells, the expression of myocilin is under
the influence of FGF-2 and TGF-b1 [13, 30]. As both
growth factors critically contribute to the pathogenetic
events during experimental glomerulonephritis [33–35],
we investigated the expression of myocilin in experi-
mental anti-Thy 1 nephritis. The substantial induction
of mesangial myocilin immunostaining that was found
under these conditions correlated with the increase in
mesangial a-SMA expression and fibronectin synthesis,
which has been described previously [33, 36]. We also ob-
served clear evidence for an extracellular localization of
myocilin in the mesangium of some affected glomeruli.
At present, the functional role of myocilin during anti-
Thy 1 nephritis is as unclear as that in the normal kid-
ney. We assume that mesangial myocilin in the inflamed
glomerulus has rather a regulatory than a structural
function, and may interact with cell-surface receptors,
extracellular matrix, growth factors, and/or proteases. A
similar role has been shown for matricellular proteins
such as thrombospondin-1, secreted protein, acidic and
rich in cysteine (SPARC) or tenascin, which are all up-
regulated during experimental glomerulonephritis [57–
60]. Clearly, more studies are needed to establish a ma-
tricellular function for mesangial myocilin.
Mutations in myocilin are causative for some forms of
primary open-angle glaucoma [17] and affected patients
suffer from high intraocular pressures because of a dys-
function of the aqueous humor outflow system [5]. So
far, all available data indicate that mutated myocilin is
not secreted, but accumulates within cells [26, 41, 42]. Up
to now, it is unclear how the lack of secretion causes criti-
cal problems in aqueous humor outflow, but a dominant-
negative or gain-of-function mechanism appears to be
the most likely hypothesis [5]. Whatever the mechanism
might be, by which mutations in myocilin cause glaucoma,
it is obviously not relevant for the proper function of the
kidney as affected patients do not have apparent kidney
problems [19]. In contrast to the eye, compensatory mech-
anisms appear to be active in the kidney that compen-
sate for dominant-negative or other effects of mutated
myocilin.
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